REBECCA STRUNK-LAIL: Open Payments
NPI 1306232079 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,858 in 157 payments from 20 companies in 2025. Trend: 2023 $135 · 2024 $2,221 · 2025 $2,858
Food & beverage: $2,858
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $553 |
| GENZYME CORPORATION | 13 | $290 |
| Galderma Laboratories, L.P. | 26 | $243 |
| Incyte Corporation | 8 | $203 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $182 |
| UCB, Inc. | 6 | $172 |
| Novartis Pharmaceuticals Corporation | 4 | $168 |
| E.R. Squibb & Sons, L.L.C. | 13 | $167 |
| Janssen Biotech, Inc. | 8 | $163 |
| Regeneron Healthcare Solutions, Inc. | 6 | $147 |
Products named: DUPIXENT, SKYRIZI, OPZELURA, Bimzelx, Sotyktu, RINVOQ, TREMFYA, ILUMYA.
Industry payments across NC — which companies pay providers there.
